Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer

BACKGROUND: Relatives of BRCA1 and BRCA2 mutation carriers have long been proposed by epidemiological studies to have an increased risk of developing prostate cancer. In the Ashkenazi Jewish (AJ) population, the existence of 3 frequent founder mutations, 185delAG and 5382insC in BRCA1 and 6174delT i...

ver descrição completa

Detalhes bibliográficos

Publicado no:	BMC Med Genet
Principais autores:	Hamel, Nancy, Kotar, Kimberley, Foulkes, William D
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2003
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC194219/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12911837/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2350-4-7
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!